Intratympanic vs Systemic Corticosteroids in First-line Treatment of Idiopathic Sudden Sensorineural Hearing Loss

Abstract

IMPORTANCETo our knowledge, evidence-based recommendations on the intratympanic vs systemic administration of corticosteroids for the treatment of idiopathic sudden sensorineural hearing loss remain unestablished, and contradictory conclusions have been reported in previous meta-analyses.OBJECTIVE To compare recovery from idiopathic sudden sensorineural hearing loss based on systemic, intratympanic, or a combined treatment with corticosteroids as first-line treatment.DATA SOURCES We adhered to the Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines. We searched PubMed, Embase, OvidSP, CINAHL, and Cochrane Library from January 1, 1966, to July 1, 2018. This study was registered in the International Prospective Register of Systematic Reviews (CRD42018109314). STUDY SELECTIONWe included randomized studies. Included studies must have excluded identifiable causes. Corticosteroids must have been administered solitarily. We excluded studies that did not define hearing loss as a minimum 30 dB within 72 hours. DATA EXTRACTION AND SYNTHESISWe identified 170 titles, of which 56 (32.9%) were eligible for full-text screening. We independently extracted data. We applied a fixed-effects model to investigate our objectives. MAIN OUTCOMES AND MEASUREWe aimed to (1) estimate the difference in mean pure tone average (PTA) gain in decibels from intratympanic treatment vs systemic treatment and (2) investigate odds ratios for recovery between the different treatment groups. RESULTSWe included 7 eligible studies. A total of 710 patients were allocated to receive either intratympanic treatment (IT group, 235 [33%]), systemic treatment (ST group; 325 [46%]) or combined intratympanic and systemic treatment (CB group; 150 [21%]). The PTA was measured by taking the mean of 4 frequencies: 4 studies measured at 500, 1000, 2000, and 3000 Hz and 3 studies measured at 500, 1000, 2000, and 4000 Hz. The ST group had a 2.01-dB higher PTA gain (95% CI, −5.61 dB to 1.59 dB; P = .96; I 2 = 0%) compared with the IT group and the odds for achieving complete recovery was not significantly different at an odds ratio of 0.94 (95% CI, 0.61 to 1.44; P = .19; I 2 = 34.5%). For the CB group vs the ST group, the odds ratio was 1.11 (95% CI, 0.68 to 1.82; P = .75; I 2 = 0%). The analysis of the CB group vs IT group comprised only 2 studies.CONCLUSIONS AND RELEVANCE This study does not suggest that corticosteroid delivered intratympanically is more beneficial than systemic treatment in the case of moderate to severe idiopathic sudden sensorineural hearing loss. There were no indications that combined treatment was associated with improved hearing outcomes compared with either systemic or intratympanic treatment.

Sudden Sensorineural Hearing Loss in Mild COVID-19: Case Series and Analysis of the Literature

“…Once they had been referred to our ENT Department for the sudden onset of SSNHL, all patients received oral high dose prednisone therapy (60 mg/day) [ 31 , 32 , 33 ], oral mesoglycan (50 mg, twice a day) [ 34 , 35 ] and Hyperbaric Oxygen Therapy (HBOT) [ 36 , 37 , 38 , 39 ]. During HBOT, 100% oxygen was provided at a pressure of 2.5 ATA, in sessions of 1 h per day.…”

Comparison among Three Different Steroid Therapies for Idiopathic Sudden Sensorineural Hearing Loss

“…However, recent meta-analysis showed negative results regarding the effect of steroids. 13,14) Althouth the risk-to-benefit ratio and the efficacy of steroids remain obscure, some large observational studies showed beneficial effects of its use in ISSNHL. Therefore, recent clinical guidelines suggest that steroid therapy within two weeks of symptom onset could be an option for the treatment of ISSNHL.…”

Factors Affecting Intratympanic Corticosteroids Injection Therapy Results in Sudden Deafness Patients at Dr Mohammad Hoesin Hospital Palembang

“…Corticosteroids work by reducing inflammation, edema, modulating the immune system in the inner ear, increasing the microcirculation of the inner ear, having an antioxidant effect, and playing a role in ion and water homeostasis. 2,22,24 Corticosteroids also aim to improve nerve function. Corticosteroids reach the inner ear via a systemic route via intratympanic steroid injection and increase blood flow to the inner ear.…”